Valens Semiconductor Ltd. (NYSE:VLN) reported first-quarter 2026 revenue of $16.9 million, compared with $19.4 million in the fourth quarter of 2025 and $16.8 million in the first quarter of 2025, according to an update from Stonegate Capital Partners. While revenue declined sequentially from a stronger Q4 2025, results modestly exceeded expectations, and management reiterated its full-year 2026 revenue guidance of $75.0 million to $77.0 million.
The company reported GAAP gross margin of 62.2%, above its guidance range of 57.0% to 59.0%. Adjusted EBITDA loss was $(5.5) million, better than the guided range of $(7.9) million to $(7.5) million. Stonegate noted that Valens continues to view 2026 as a year of measured recovery and product-cycle execution, with near-term growth expected to build through the year as the Core Infrastructure Business (CIB) returns to sequential growth, automotive remains steady, and the A-PHY ecosystem development continues.
Management stated that broader supply-chain conditions remain an area to monitor but importantly does not see risk to meeting its full-year targets. The second half of 2026 is expected to see a meaningful acceleration, driven by CIB sequential growth, ProAV momentum, and design wins and design-ins converting into customer launches in the third and fourth quarters.
Automotive revenue grew to $5.9 million in the quarter. The VA7000 market, which addresses industrial machine vision and medical endoscopy applications, expands the addressable opportunity beyond core A-PHY automotive applications, though revenue contribution from these areas likely remains several quarters out.
For more details, see the full announcement here. Stonegate Capital Partners is a capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Its affiliate, Stonegate Capital Markets (member FINRA), offers investment banking services.
